Back to Nephrology
Nephrologyv2024Evidence-Based

Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator

Predicts the risk of acute kidney injury in patients treated with intravenous cisplatin. This calculator estimates the probability of moderate to severe AKI (≥2-fold rise in serum creatinine or need for kidney replacement therapy within 14 days of cisplatin administration).

Clinical Input Parameters

years
Range: 18 — 110 years
mg
Range: 1 — 1000 mg
g/dL
Range: 2 — 20 g/dL
×10³/µL
Range: 1 — 300 ×10³/µL
×10³/µL
Range: 1 — 1500 ×10³/µL
g/dL
Range: 0.5 — 8 g/dL
mg/dL
Range: 0.5 — 5 mg/dL
Clinical Assessment
Awaiting Parameters
cp aki risk
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within nephrology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Risk (%) = 1 / (1 + e^(-X)) × 100, where X is calculated using patient characteristics including age, comorbidities, and laboratory values

Clinical Pearls & Practice Notes

  • This calculator predicts moderate to severe AKI, defined as ≥2-fold rise in serum creatinine or need for kidney replacement therapy within 14 days
  • Derived from a cohort of 24,717 patients across 6 US academic cancer centers (2006-2022)
  • Model achieved c-statistic of 0.75, outperforming previous risk models
  • Risk calculator available at https://kidneycalc.org/cp-aki-calculator/
  • Consider alternative chemotherapy regimens in high-risk patients

Evidence & Literature Citations

  1. Gupta S, Portales-Castillo I, Daher A, Kitchlu A. Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study. BMJ. 2024 Mar 27;384:e077169. doi: 10.1136/bmj-2023-077169.
  2. Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC. Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 Mar 1;36(7):682-688. doi: 10.1200/JCO.2017.75.7161.

Score Interpretation Ranges

Tier 10 – 5 pts

Low risk

Tier 25 – 15 pts

Moderate risk

Tier 315 – 30 pts

High risk

Tier 430 – 100 pts

Very high risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.